D Bellgrau
Overview
Explore the profile of D Bellgrau including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
643
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jubala C, Wojcieszyn J, Valli V, Getzy D, Fosmire S, Coffey D, et al.
Vet Pathol
. 2005 Jul;
42(4):468-76.
PMID: 16006606
We examined the expression of CD20 in normal canine peripheral blood mononuclear cells, normal canine spleen, and canine non-Hodgkin lymphoma (NHL) to determine the feasibility of using this antigen as...
2.
Duke R, Setser E, Nelson D, Bellgrau D
Transplant Proc
. 2002 Dec;
34(8):3396-8.
PMID: 12493481
No abstract available.
3.
LANG J, Bellgrau D
Scand J Immunol
. 2002 May;
55(6):546-59.
PMID: 12028557
The genetic basis and familial clustering of autoimmunity suggest that common phenotypic traits predispose individuals to disease. We found a hyporesponsive T-cell phenotype that was shared by all autoimmune-prone mouse...
4.
Stubbs A, Martin K, Coeshott C, Skaates S, Kuritzkes D, Bellgrau D, et al.
Nat Med
. 2001 May;
7(5):625-9.
PMID: 11329066
There is currently a need for vaccines that stimulate cell-mediated immunity-particularly that mediated by CD8+ cytotoxic T lymphocytes (CTLs)-against viral and tumor antigens. The optimal induction of cell-mediated immunity requires...
5.
Moore J, Scheinman R, Bellgrau D
J Immunol
. 2000 Dec;
166(1):241-8.
PMID: 11123298
The cyclin-dependent kinase inhibitor p27(kip) regulates the cell cycle at the G(1)-S phase restriction point. S phase entry and cell cycle commitment in peripheral T cells requires p27(kip) degradation, normally...
6.
Nelson D, Setser E, Hall D, Schwartz S, Hewitt T, Klevitsky R, et al.
J Clin Invest
. 2000 May;
105(9):1199-208.
PMID: 10791994
Expression of Fas ligand (FasL) renders certain tissues immune privileged, but its expression in other tissues can result in severe neutrophil infiltration and tissue destruction. The consequences of enforced FasL...
7.
Bellgrau D, Duke R
Int Rev Immunol
. 2000 Feb;
18(5-6):547-62.
PMID: 10672501
No abstract available.
8.
Moore J, Gold D, Dreskin S, Lernmark A, Bellgrau D
Cell Immunol
. 1999 Jun;
194(1):90-7.
PMID: 10357884
T cell fate following antigen encounter is determined by several intracellular signals generated by the interaction of the T cell with an antigen-presenting cell. In the periphery activation requires T...
9.
Moore J, Bellgrau D
Transplant Proc
. 1999 May;
31(3):1606-10.
PMID: 10331020
No abstract available.
10.
Duke R, Newell E, Schleicher M, Meech S, Bellgrau D
Transplant Proc
. 1999 May;
31(3):1479-81.
PMID: 10330975
No abstract available.